This analytical procedure is a common method used to identify the presence of multiple illicit substances and prescription medications within a biological sample, typically urine. The process involves employing a series of immunoassays or chromatographic techniques to detect various drug metabolites or the parent drug compound itself. Results offer a qualitative indication of whether a substance is present above a predetermined cutoff concentration. For example, a single analysis might simultaneously screen for amphetamines, opiates, cannabinoids, cocaine metabolites, and benzodiazepines.
The employment of this testing methodology plays a significant role in various settings, including pre-employment screening, workplace safety programs, clinical toxicology, and monitoring adherence to prescribed medication regimens. Its utility stems from the capacity to efficiently and cost-effectively detect a broad spectrum of substances, contributing to improved safety, accountability, and the prevention of substance abuse. Historically, these types of analyses have evolved from single-analyte tests to the current comprehensive formats to meet the growing need for broader substance detection.
